DK1546119T3 - Fremgangsmåde til fremstilling af 4-(3'chlor-4'-fluoranilin)-7-methoxy-6-(3-morpholinpropoxy) quinazoline - Google Patents
Fremgangsmåde til fremstilling af 4-(3'chlor-4'-fluoranilin)-7-methoxy-6-(3-morpholinpropoxy) quinazolineInfo
- Publication number
- DK1546119T3 DK1546119T3 DK03795077T DK03795077T DK1546119T3 DK 1546119 T3 DK1546119 T3 DK 1546119T3 DK 03795077 T DK03795077 T DK 03795077T DK 03795077 T DK03795077 T DK 03795077T DK 1546119 T3 DK1546119 T3 DK 1546119T3
- Authority
- DK
- Denmark
- Prior art keywords
- methoxy
- quinazoline
- chloro
- fluoroaniline
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0221245.4A GB0221245D0 (en) | 2002-09-13 | 2002-09-13 | Chemical process |
| PCT/GB2003/003923 WO2004024703A1 (en) | 2002-09-13 | 2003-09-09 | Process for the preparation of 4- (3’-chloro-4’-fluoroanilino) -7-methoxy-6- (3-morpholinopropoxy) quinazoline |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1546119T3 true DK1546119T3 (da) | 2009-11-16 |
Family
ID=9943998
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03795077T DK1546119T3 (da) | 2002-09-13 | 2003-09-09 | Fremgangsmåde til fremstilling af 4-(3'chlor-4'-fluoranilin)-7-methoxy-6-(3-morpholinpropoxy) quinazoline |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7705145B2 (da) |
| EP (1) | EP1546119B1 (da) |
| JP (2) | JP4527534B2 (da) |
| KR (1) | KR101114134B1 (da) |
| CN (3) | CN102030722B (da) |
| AT (1) | ATE440088T1 (da) |
| AU (1) | AU2003263348B2 (da) |
| BR (1) | BRPI0314238B8 (da) |
| CA (1) | CA2498122C (da) |
| CY (1) | CY1110511T1 (da) |
| DE (1) | DE60328901D1 (da) |
| DK (1) | DK1546119T3 (da) |
| ES (1) | ES2329567T3 (da) |
| GB (1) | GB0221245D0 (da) |
| HK (1) | HK1077809A1 (da) |
| IL (1) | IL167209A (da) |
| MX (1) | MXPA05002601A (da) |
| NO (1) | NO330009B1 (da) |
| NZ (1) | NZ538552A (da) |
| PT (1) | PT1546119E (da) |
| SI (1) | SI1546119T1 (da) |
| WO (1) | WO2004024703A1 (da) |
| ZA (1) | ZA200501892B (da) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005070909A1 (en) * | 2004-01-22 | 2005-08-04 | Natco Pharma Limited | An improved process for the preparation of gefitinib |
| US8350029B2 (en) | 2007-04-16 | 2013-01-08 | Cipla Limited | Process for the preparation of gefitinib |
| CN101463012B (zh) * | 2007-12-18 | 2011-06-08 | 上海百灵医药科技有限公司 | 一种吉非替尼的制备方法 |
| CN101215274B (zh) * | 2007-12-27 | 2011-05-04 | 上海北卡医药技术有限公司 | N取代吗啉类有机化合物的制备工艺 |
| CN101570516B (zh) * | 2009-04-14 | 2011-01-05 | 重庆威尔德·浩瑞医药化工有限公司 | 一种制备4-(3-氯-4-氟苯基胺基)-7-甲氧基-6-[3-(4-吗啉基)丙氧基]喹唑啉的方法 |
| CN101863844B (zh) * | 2009-04-16 | 2012-10-03 | 欧美嘉股份有限公司 | 6,7-取代基-4-苯胺类喹唑啉的合成方法 |
| CN102120731B (zh) * | 2010-01-09 | 2015-01-07 | 浙江华海药业股份有限公司 | 一种制备4-(3-氯-4-氟苯基胺基)-7-甲氧基-6-(3-吗啉丙氧基)喹唑啉的新方法 |
| CN102659716B (zh) * | 2012-05-02 | 2014-09-10 | 北京国联诚辉医药技术有限公司 | 4-甲氧基-2-胺基-3-[3-(4-吗啉基)丙氧基]苯腈的制备方法及吉非替尼的制备工艺 |
| KR101457453B1 (ko) * | 2012-05-31 | 2014-11-04 | 주식회사 종근당 | 게피티닙의 제조방법 및 이의 제조에 사용되는 중간체 |
| CN103073509A (zh) * | 2012-12-31 | 2013-05-01 | 广东先强药业有限公司 | 一类喹唑啉衍生物的制备方法 |
| CN103910690A (zh) * | 2013-01-06 | 2014-07-09 | 上海科胜药物研发有限公司 | 一种吉非替尼新晶型及其制备方法 |
| JP6020191B2 (ja) * | 2013-01-21 | 2016-11-02 | 富士ゼロックス株式会社 | 表示制御装置及びプログラム |
| CN103254156B (zh) * | 2013-05-10 | 2015-08-26 | 苏州明锐医药科技有限公司 | 阿法替尼中间体的制备方法 |
| CN103304491A (zh) * | 2013-06-17 | 2013-09-18 | 连云港盛和生物科技有限公司 | 一种吉非替尼的制备方法 |
| CN104130199A (zh) * | 2013-08-07 | 2014-11-05 | 安徽安腾药业有限责任公司 | 制备7-甲氧基-6-(3-吗啉-4-基丙氧基)喹唑啉-4(3h)-酮的方法 |
| CN105254614B (zh) * | 2015-11-16 | 2017-08-15 | 山东罗欣药业集团股份有限公司 | 一种凡德他尼化合物的合成方法 |
| CN109384747A (zh) * | 2018-10-26 | 2019-02-26 | 苏州立新制药有限公司 | 吉非替尼相关物质及其制备和检测方法 |
| CN115108999B (zh) * | 2019-07-26 | 2023-11-03 | 暨南大学 | 一种苯基哌嗪喹唑啉类化合物或其药学上可接受的盐、制法与用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9300059D0 (en) | 1992-01-20 | 1993-03-03 | Zeneca Ltd | Quinazoline derivatives |
| GB9508538D0 (en) * | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quinazoline derivatives |
| DE69838172T2 (de) * | 1997-08-22 | 2008-04-10 | Astrazeneca Ab | Oxindolylchinazolinderivate als angiogenesehemmer |
| JP3505991B2 (ja) | 1998-02-13 | 2004-03-15 | 宇部興産株式会社 | ４，５−ジ置換アントラニルアミドの製造法 |
| JP3740835B2 (ja) * | 1998-04-03 | 2006-02-01 | 宇部興産株式会社 | ６，７−ジ置換−２，４−ジオキソキナゾリンの製造法 |
| MXPA01012887A (es) * | 1999-07-07 | 2002-07-30 | Astrazeneca Uk Ltd | Derivados de quinazolina. |
| AU2001266505A1 (en) * | 2000-06-28 | 2002-01-08 | Astrazeneca Ab | Substituted quinazoline derivatives and their use as inhibitors |
| AU2002222606A1 (en) | 2000-12-12 | 2002-06-24 | Ube Industries Ltd. | Process for producing mononitrated aromatic ether compound |
| ATE519748T1 (de) | 2001-12-19 | 2011-08-15 | Ube Industries | Verfahren zur herstellung von chinazolin-4-on und derivaten davon |
| WO2003064377A1 (fr) | 2002-01-29 | 2003-08-07 | Ube Industries, Ltd. | 2-formylaminobenzamides-4,5 substitues et methodes de production et de conversion desdits composes |
| WO2003066602A1 (fr) | 2002-02-06 | 2003-08-14 | Ube Industries, Ltd. | Procede relatif a l'elaboration d'un compose 4-aminoquinazoline |
-
2002
- 2002-09-13 GB GBGB0221245.4A patent/GB0221245D0/en not_active Ceased
-
2003
- 2003-09-09 MX MXPA05002601A patent/MXPA05002601A/es active IP Right Grant
- 2003-09-09 CN CN2010105455522A patent/CN102030722B/zh not_active Expired - Lifetime
- 2003-09-09 NZ NZ538552A patent/NZ538552A/en not_active IP Right Cessation
- 2003-09-09 AU AU2003263348A patent/AU2003263348B2/en not_active Expired
- 2003-09-09 JP JP2004535657A patent/JP4527534B2/ja not_active Expired - Lifetime
- 2003-09-09 KR KR1020057004294A patent/KR101114134B1/ko active IP Right Grant
- 2003-09-09 EP EP03795077A patent/EP1546119B1/en not_active Expired - Lifetime
- 2003-09-09 US US10/527,461 patent/US7705145B2/en not_active Expired - Fee Related
- 2003-09-09 AT AT03795077T patent/ATE440088T1/de active
- 2003-09-09 CN CNB038215500A patent/CN100429204C/zh not_active Expired - Lifetime
- 2003-09-09 BR BRPI0314238A patent/BRPI0314238B8/pt active IP Right Grant
- 2003-09-09 PT PT03795077T patent/PT1546119E/pt unknown
- 2003-09-09 DE DE60328901T patent/DE60328901D1/de not_active Expired - Lifetime
- 2003-09-09 WO PCT/GB2003/003923 patent/WO2004024703A1/en active Application Filing
- 2003-09-09 SI SI200331674T patent/SI1546119T1/sl unknown
- 2003-09-09 ES ES03795077T patent/ES2329567T3/es not_active Expired - Lifetime
- 2003-09-09 CA CA2498122A patent/CA2498122C/en not_active Expired - Fee Related
- 2003-09-09 DK DK03795077T patent/DK1546119T3/da active
- 2003-09-09 CN CN2008102128004A patent/CN101348471B/zh not_active Expired - Lifetime
-
2005
- 2005-03-01 NO NO20051104A patent/NO330009B1/no not_active IP Right Cessation
- 2005-03-02 IL IL167209A patent/IL167209A/en active IP Right Grant
- 2005-03-04 ZA ZA2005/01892A patent/ZA200501892B/en unknown
- 2005-10-28 HK HK05109628.6A patent/HK1077809A1/xx not_active IP Right Cessation
-
2009
- 2009-10-15 CY CY20091101076T patent/CY1110511T1/el unknown
-
2010
- 2010-03-18 JP JP2010061976A patent/JP2010209071A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1077809A1 (en) | Process for the preparation of 4-(3'chloro-4'-fluoroanilino)-7-methoxy-6- (3-morpholinopropoxy) quinazoline | |
| DK1289972T3 (da) | Serinproteaseinhibitorer | |
| ATE371656T1 (de) | Heteroaryl-pyrimidinderivate als jak-inhibitoren | |
| MXPA06000716A (es) | Derivados de quinolina y quinazolina que tienen afinidad hacia receptores del tipo 5ht1. | |
| ATE397601T1 (de) | Pyridin-4-yl-ethynylimidazole und -pyrazole als antagonisten des mglu5-rezeptors | |
| ATE386530T1 (de) | Chinazoline derivate und ihre anwendung in der krebsbehandlung | |
| ATE355278T1 (de) | Isochinolinon derivate als parp inhibitoren | |
| BRPI0407520A (pt) | polimorfo de {6,7-bis(2-metóxi-etóxi)-quinazolin-4-il}-(3e) | |
| ATE301122T1 (de) | Kernerweiterte perylenbisimide und ihre verwendung als fluoreszenzfarbstoffe | |
| ATE291024T1 (de) | Neue 4-aminofuropyrimidine und ihre verwendung | |
| DE502005008351D1 (de) | Chinolinderivat, dessen verwendung, herstellung und dieses enthaltendes arzneimittel | |
| ATE347555T1 (de) | 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung | |
| ATE303384T1 (de) | 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren | |
| DE60023025D1 (de) | 3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p39-kinase-inhibitoren | |
| DE60108626D1 (de) | Verwendung von 5-thio, sulfinyl- und sulfonylpyrazolo 3,4-b] pyridinen als cyclin-abhängige kinase-hemmer | |
| ATE369348T1 (de) | Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie | |
| DE69927689D1 (de) | Lipid-senkende chinazoline derivate | |
| MY145540A (en) | Chemical process | |
| MXPA04004981A (es) | Derivados de piperazina para uso como antagonistas del receptor ccr-3 en tratamiento de asma. | |
| DE60311887D1 (de) | Multifunktionelle kationische photoinitiatoren, deren herstellung und verwendung | |
| DE602004005016D1 (de) | Biphenylcarboxamidderivate und ihre verwendung als p38 kinase inhibitoren | |
| DE50210348D1 (de) | 2-heteroaryl-3,4-dihydro-2h-pyrrol-derivate und ihre verwendung als schädlingsbekämpfungsmittel | |
| BR0212451A (pt) | Antagonistas de receptores de ccr-3 v | |
| BR0112082A (pt) | Formas polimórficas/hidratos do dicloridrato de n-[4-(3cloro-4-fluorofenilamino)-7-(3-morfolin-4-ilpro póxi)-quinazolin-6-il)-acrilamida | |
| PT1387837E (pt) | Novos derivados de azole e de triazole, processo para a sua preparacao e sua aplicacao como medicamentos anti-fungicos |